What is the initial management of Post-Streptococcal Glomerulonephritis (PSGN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Management of Post-Streptococcal Glomerulonephritis (PSGN)

The initial management of Post-Streptococcal Glomerulonephritis (PSGN) primarily consists of supportive care, antibiotic therapy to eliminate remaining streptococcal organisms, and targeted treatment of complications such as hypertension and fluid overload. 1

Antibiotic Treatment

  • Penicillin or erythromycin (if penicillin-allergic) for 10 days is recommended to eliminate any remaining streptococcal organisms 1
  • This treatment does not alter the course of established PSGN but prevents spread to others and reduces the risk of rheumatic fever

Supportive Care Measures

Fluid and Sodium Management

  • Restrict sodium intake (<2.0 g/day) to help control edema and hypertension 1
  • Implement fluid restriction in patients with significant edema or hypertension
  • Monitor for signs of volume overload (pulmonary congestion, peripheral edema)

Blood Pressure Control

  • Hypertension occurs in up to 95% of patients in the acute phase but is typically mild and short-term 2
  • First-line treatment: Loop diuretics (primarily furosemide) to manage both hypertension and edema 2
  • For persistent hypertension: Consider ACE inhibitors or ARBs at maximally tolerated doses 1
  • Target systolic BP <120 mmHg in most adult patients 1
  • Most patients normalize blood pressure within 3-5 days as glomerular filtration rate improves and edema resolves 2

Monitoring Parameters

  • Daily weight measurements
  • Strict intake and output monitoring
  • Regular blood pressure checks
  • Renal function tests (BUN, creatinine)
  • Electrolytes (particularly potassium and sodium)
  • Urinalysis to track hematuria and proteinuria

Management of Complications

Severe Hypertension

  • Treat aggressively to prevent hypertensive encephalopathy
  • Consider IV antihypertensives for hypertensive emergencies

Acute Kidney Injury

  • Most cases are mild and self-limiting
  • Avoid nephrotoxic medications
  • Renal replacement therapy is rarely needed but should be considered for:
    • Severe uremia
    • Refractory hyperkalemia
    • Pulmonary edema unresponsive to diuretics

Congestive Heart Failure/Pulmonary Edema

  • Oxygen supplementation as needed
  • Diuretics (furosemide)
  • Fluid restriction
  • Sitting position to improve ventilation

Important Considerations

  • Immunosuppression is generally not indicated for typical PSGN unless severe crescentic glomerulonephritis is present 1
  • Kidney biopsy is rarely needed and reserved for:
    • Diagnostic uncertainty
    • Rapidly progressive glomerulonephritis
    • Atypical disease progression 3
  • Most patients make a full recovery with supportive care alone 3, 4

Follow-up and Monitoring

  • Regular monitoring of renal function, urinalysis, and blood pressure
  • Long-term follow-up is recommended as a small percentage (approximately 7%) may develop persistent hypertension 2
  • Persistent proteinuria, hypertension, or abnormal renal function beyond the acute phase may require extended monitoring 4
  • Poor prognostic indicators include:
    • Persistent hypertension beyond the acute phase
    • Crescent formation on renal biopsy
    • Significant renal insufficiency at presentation 5

By following these management principles, most patients with PSGN will recover completely without long-term sequelae, though a small percentage may develop chronic kidney disease requiring ongoing care.

References

Guideline

Glomerulonephritis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute post-streptococcal glomerulonephritis in children - treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.